A Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Normal Renal Function and Subjects With Moderate-to-Severe Renal Impairment With Non-Dialysis-Dependent Renal Insufficiency (NDDRI)
Phase of Trial: Phase I
Latest Information Update: 26 May 2014
At a glance
- Drugs Tirofiban (Primary)
- Indications Arterial thrombosis; Myocardial infarction; Unstable angina pectoris
- Focus Pharmacokinetics
- Sponsors Medicure
- 26 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Feb 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Jan 2013 New trial record